Lanyue Biotech (Hangzhou) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Lanyue Biotech (Hangzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I (NCT07554924) | Lanyue Biotech (Hangzhou) Co., Ltd. | 2026-05-15 |
Track Lanyue Biotech (Hangzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.